Concepedia

Mark Laughlin

ML

Statistics

Publications

22

Citations

3K

H-Index

18

Active since

1978

Affiliations

University of Pennsylvania(Current)

Myriad Genetics

Jefferson College

Thomas Jefferson University

Sunnybrook Health Science Centre

Mark Laughlin is an author at University of Pennsylvania specializing in pharmacology, life sciences, and medicine.

Publications per year

1978–2012

22

Publications

22

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

Janet M. Harouse, Shama Bhat, Steven L. Spitalnik et al. · Science · 1991 · 519 citations

, , +12

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

Rachel Courtney, David Wexler, Elaine Radwanski et al. · British Journal of Clinical Pharmacology · 2003 · 325 citations · Full text

, , +17

Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults

Rachel Courtney, Sudhakar M. Pai, Mark Laughlin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 301 citations · Full text

, , +14

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

Gordon Wilcock, Sandra E. Black, Suzanne Hendrix et al. · The Lancet Neurology · 2008 · 295 citations

, , +12

CD4-independent infection of human neural cells by human immunodeficiency virus type 1

Janet M. Harouse, C Kunsch, Heather T. Hartle et al. · Journal of Virology · 1989 · 290 citations · Full text

, , +11

1–5 of 22